Basic information about inhibitors

IPAD-DB ID	S00044
Name	(5, 7-Dichloro-8-hydroxyquinolin-2-yl)methyl-4-(1H-indole-2-carbonyl)piperazine-1-carboxylate
Category	Synthetic compounds
2D Structure
3D Structure
Molecular Formula	C 2 4 H 2 0 C l 2 N 4 O 4
Molecular Weight	499.3 g/mol
IUPAC Name	(5, 7-dichloro-8-hydroxyquinolin-2-yl)methyl 4-(1H-indole-2-carbonyl)piperazine-1-carboxylate
InChI	InChI=1S/C24H20Cl2N4O4/c25-17-12-18(26)22(31)21-16(17)6-5-15(27-21)13-34-24(33)30-9-7-29(8-10-30)23(32)20-11-14-3-1-2-4-19(14)28-20/h1-6, 11-12, 28, 31H, 7-10, 13H2
InChIKey	CIKQNDUTXXFOFM-UHFFFAOYSA-N
Canonical SMILES	C1CN(CCN1C(=O)C2=CC3=CC=CC=C3N2)C(=O)OCC4=NC5=C(C=C4)C(=CC(=C5O)Cl)Cl
PubChem CID	162395700
DrugBank Accession Number	-
CAS Registry Number	-

Biological activity data

Ki	-
EC50	1.72 μM(self-induced Aβ1-42 aggregation)
IC50
Inhibition
Toxicity
ROS(reactive oxygen species)
Metal Chelating
BBB(blood-brain barrier)
Target Protein	Aβ1-42
Effects	Inhibit self-induced Aβ1-42 aggregation, reduce protein aggregation in HEK-tau and SY5Y-APPsw cells
Research Models	Molecular Docking, in HEK-tau and SY5Y-APPSw cells
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME)	499.35
Hac(Computed by SwissADME)	34
Volume(Computed by ADMETlab 2.0)	461.447
Density(Computed by ADMETlab 2.0)	1.079
nRing(Computed by ADMETlab 2.0)	5
MaxRing(Computed by ADMETlab 2.0)	10
nHet(Computed by ADMETlab 2.0)	10
fChar(Computed by ADMETlab 2.0)	0
nRig(Computed by ADMETlab 2.0)	29
Flexibility(Computed by ADMETlab 2.0)	0.207
Stero Centers(Computed by ADMETlab 2.0)	0
LogS(Computed by ADMETlab 2.0)	-4.496
LogD(Computed by ADMETlab 2.0)	3.662

ADMET properties

logP(Computed by ADMETlab 2.0)	4.476
TPSA(Computed by SwissADME)	98.76
Hbond Acceptor(Computed by SwissADME)	5
Hbond Donor(Computed by SwissADME)	2
Rotatable Bonds(Computed by SwissADME)	6

Pharmacokinetics

GI Absorption(Computed by SwissADME)	High
BBB(blood-brain barrier) Permeant(Computed by SwissADME)	No
P-gp Substrate(Computed by SwissADME)	Yes
CYP1A2 Inhibitor(Computed by SwissADME)	No
CYP2C19 Inhibitor(Computed by SwissADME)	Yes
CYP2C9 Inhibitor(Computed by SwissADME)	Yes
CYP2D6 Inhibitor(Computed by SwissADME)	Yes
CYP3A4 Inhibitor(Computed by SwissADME)	Yes
log Kp(Skin Permeation)(Computed by SwissADME)	-6.35

Druglikeness

Lipinski(Computed by SwissADME)	0
Ghose(Computed by SwissADME)	2
Veber(Computed by SwissADME)	0
Egan(Computed by SwissADME)	0
Muegge(Computed by SwissADME)	0
Bioavailability Score(Computed by SwissADME)	0.55